3-128485888-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032638.5(GATA2):​c.710G>A​(p.Gly237Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,614,026 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G237S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0030 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 29 hom. )

Consequence

GATA2
NM_032638.5 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.81
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008027881).
BP6
Variant 3-128485888-C-T is Benign according to our data. Variant chr3-128485888-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 343139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128485888-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00305 (464/152224) while in subpopulation NFE AF= 0.000485 (33/68002). AF 95% confidence interval is 0.000354. There are 8 homozygotes in gnomad4. There are 359 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 464 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GATA2NM_001145661.2 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 4/7 ENST00000487848.6
GATA2NM_032638.5 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 3/6 ENST00000341105.7
GATA2NM_001145662.1 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 3/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GATA2ENST00000341105.7 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 3/61 NM_032638.5 P1P23769-1
GATA2ENST00000487848.6 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 4/71 NM_001145661.2 P1P23769-1
GATA2ENST00000430265.6 linkuse as main transcriptc.710G>A p.Gly237Asp missense_variant 3/61 P23769-2
GATA2ENST00000696466.1 linkuse as main transcriptc.992G>A p.Gly331Asp missense_variant 5/8

Frequencies

GnomAD3 genomes
AF:
0.00305
AC:
464
AN:
152106
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0402
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00353
AC:
886
AN:
250778
Hom.:
14
AF XY:
0.00357
AC XY:
485
AN XY:
135710
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0379
Gnomad NFE exome
AF:
0.000459
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00139
AC:
2025
AN:
1461802
Hom.:
29
Cov.:
33
AF XY:
0.00134
AC XY:
975
AN XY:
727194
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0329
Gnomad4 NFE exome
AF:
0.000195
Gnomad4 OTH exome
AF:
0.000745
GnomAD4 genome
AF:
0.00305
AC:
464
AN:
152224
Hom.:
8
Cov.:
32
AF XY:
0.00482
AC XY:
359
AN XY:
74408
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0402
Gnomad4 NFE
AF:
0.000485
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000251
Hom.:
0
Bravo
AF:
0.000185
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00228
AC:
277
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMar 04, 2016- -
GATA2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 08, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 21, 2024- -
Deafness-lymphedema-leukemia syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Acute myeloid leukemia;C3279664:Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections;C3463824:Myelodysplastic syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 14, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.52
D;.;D
Eigen
Benign
-0.030
Eigen_PC
Benign
0.061
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.89
.;D;D
MetaRNN
Benign
0.0080
T;T;T
MetaSVM
Uncertain
0.67
D
MutationAssessor
Benign
1.8
L;L;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Uncertain
0.40
Sift
Benign
0.067
T;T;T
Sift4G
Benign
0.22
T;T;T
Polyphen
0.38
B;B;B
Vest4
0.78
MVP
0.70
MPC
0.80
ClinPred
0.027
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.20
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs191501191; hg19: chr3-128204731; API